Write from this board Add posts Share
Loading the board
Loading the board
80 posts from @GileadSciences, Nov 2025 to Aug 2026: a typical post earns 9 likes. That is more than 61% of the 275 other S&P 500 companies we hold content for. About 1 in 4 of their posts opens with a number.
| Post | Topic | Likes | Replies | Reposts | Score | Posted | Actions |
|---|---|---|---|---|---|---|---|
| @GileadSciencesCue the highlights: standout moments, innovative science and meaningful progress across Gi… | Hiring | 30 | 0 | — | 14 | ||
| @GileadSciences#GileadNews: The U.S. FDA approves first and only single-tablet regimen for the treatment … | General | 26 | 2 | — | 15 | ||
| @GileadSciences#GileadNews: The U.S. FDA has accepted our filing for our investigational once-weekly oral… | General | 20 | 0 | — | 10 | ||
| @GileadSciencesEvery patient’s journey is unique, and their powerful stories inspire our commitment to ad… | General | 18 | 8 | — | 17 | ||
| @GileadSciencesWe create possibilities when great minds, cutting-edge technology and bold vision converge… | AI | 17 | 0 | — | 9 | ||
| @GileadSciencesIn an era of rapid scientific advancement and ongoing global health challenges, we’re taki… | General | 16 | 0 | — | 8 | ||
| @GileadSciences#GileadNews: Today, in collaboration with @Merck, we announced positive topline results fr… | Science | 15 | 1 | — | 9 | ||
| @GileadSciences#GileadNews: We received a #CHMP positive opinion for our combination regimen in PD-(L)1-p… | General | 14 | 5 | — | 13 | ||
| @GileadSciences#GileadNews: At #AIDS2026, in collaboration with @Merck, we’re presenting new data from ou… | General | 14 | 0 | — | 7 | ||
| @GileadSciences#GileadNews: U.S. FDA approves our treatment for first-line metastatic triple-negative bre… | General | 14 | 1 | — | 9 |